Question: Tumor mutational burden (TMB) measurement methods
[coverage] Which specific cancer types does the 2023 review identify as poorly served by the 10 mut/Mb cutoff, and what evidence supports that claim?
Collecting findings
0/5 publication-ready
Findings metrics
—
total
—
verified
—
pending
—
rejected